Tau oligomer antibodies as potential therapeutics for parkinson’s and other synucleinopathies. - Gerson, J.; Castillo-Carranza, D.L.; Sengupta, U.; Henson, N.; Nilson, A.; Kayed, R. (Journal of the Neurological Sciences, 2015)